, Tracking Stock Market Picks
Enter Symbol:
Rating: CPHD
Buy $42

Cepheid (NASDAQ: CPHD) rated to Buy with price target $42 by Stifel

Thursday,  Nov 12, 2015  8:25 AM ET by Betsy O'Brien Harrison

Stifel rated Cepheid
(NASDAQ: CPHD) to Buy with price target $42.

Cepheid, Inc. develops, manufactures and markets microfluidic systems that integrate, automate and accelerate biological testing. Their systems are miniaturized instruments that analyze complex biological samples in a disposable cartridge by combining molecular biology with microfluidic technology that processes small quantities of liquid, typically using components fabricated with computer chip technology. These systems rapidly perform all of the steps required to analyze complex biological samples.


RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy